Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02396368
Title A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer
Acronym Radium-223
Recruitment Withdrawn
Gender male
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.